AbbVie registers Phase 1 trial comparing upadacitinib, tofacitinib, baricitinib in healthy adultsSep 30Weekly roundup, 4 itemsABBV-722AbbVie
AbbVie registers Phase 3 trial of telisotuzumab adizutecan in NSCLCSep 16Trial updateAbbVietelisotuzumab adizutecan
AbbVie posts results from terminated emraclidine trial, opens two studies to recruitmentAug 21Weekly roundup, 4 itemsAbbVieemraclidine
AbbVie registers three new trials spanning obesity, head and neck cancer, and atopic dermatitisAug 7Weekly roundup, 3 itemsABBV-295AbbVie
Sign inSign in